ethinyl estradiol-norgestrel combination and mavoglurant

ethinyl estradiol-norgestrel combination has been researched along with mavoglurant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chakraborty, A; Jakab, A; Legangneux, E; Mensinga, T; Neelakantham, S; Rouzade-Dominguez, ML; Sivasubramanian, R; Ufer, M; Woessner, R	1

Trials

1 trial(s) available for ethinyl estradiol-norgestrel combination and mavoglurant

Article	Year
Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women. International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Excitatory Amino Acid Antagonists; Female; Healthy Volunteers; Humans; Indoles; Levonorgestrel; Metabolic Clearance Rate; Models, Biological; Receptor, Metabotropic Glutamate 5; Young Adult	2015

Article

Year

Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.

International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:7

Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Excitatory Amino Acid Antagonists; Female; Healthy Volunteers; Humans; Indoles; Levonorgestrel; Metabolic Clearance Rate; Models, Biological; Receptor, Metabotropic Glutamate 5; Young Adult

2015